These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16026266)

  • 61. [Role of aldose reductase inhibitors in the development of peripheral neuropathy in experimental diabetes].
    Kuchmerovskaia TM; Donchenko GV; Klimenko AP; Chichkovskaia GV; Pakirbaeva LV; Kozitskiĭ ZIa; Efimov AS
    Ukr Biokhim Zh (1978); 1997; 69(3):77-82. PubMed ID: 9505366
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CADD Studies in the Discovery of Potential ARI (Aldose Reductase Inhibitors) Agents for the Treatment of Diabetic Complications.
    Gupta SK; Tripathi PK
    Curr Diabetes Rev; 2023; 19(9):e180822207672. PubMed ID: 35993470
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase.
    Ramana KV; Friedrich B; Srivastava S; Bhatnagar A; Srivastava SK
    Diabetes; 2004 Nov; 53(11):2910-20. PubMed ID: 15504972
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tonicity-responsive enhancer binding protein regulates the expression of aldose reductase and protein kinase C δ in a mouse model of diabetic retinopathy.
    Park J; Kim H; Park SY; Lim SW; Kim YS; Lee DH; Roh GS; Kim HJ; Kang SS; Cho GJ; Jeong BY; Kwon HM; Choi WS
    Exp Eye Res; 2014 May; 122():13-9. PubMed ID: 24631337
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High levels of erythrocyte aldose reductase and diabetic retinopathy in NIDDM patients.
    Nishimura C; Saito T; Ito T; Omori Y; Tanimoto T
    Diabetologia; 1994 Mar; 37(3):328-30. PubMed ID: 8174849
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor.
    Calcutt NA; Freshwater JD; Mizisin AP
    Diabetologia; 2004 Apr; 47(4):718-24. PubMed ID: 15298349
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Aldose reductase inhibitors and their potential for the treatment of diabetic complications.
    Tomlinson DR; Stevens EJ; Diemel LT
    Trends Pharmacol Sci; 1994 Aug; 15(8):293-7. PubMed ID: 7940997
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury.
    Kaneko M; Bucciarelli L; Hwang YC; Lee L; Yan SF; Schmidt AM; Ramasamy R
    Ann N Y Acad Sci; 2005 Jun; 1043():702-9. PubMed ID: 16037296
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Polyol pathway-dependent osmotic and oxidative stresses in aldose reductase-mediated apoptosis in human lens epithelial cells: role of AOP2.
    Kubo E; Urakami T; Fatma N; Akagi Y; Singh DP
    Biochem Biophys Res Commun; 2004 Feb; 314(4):1050-6. PubMed ID: 14751239
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential Inhibitors.
    Balestri F; Quattrini L; Coviello V; Sartini S; Da Settimo F; Cappiello M; Moschini R; Del Corso A; Mura U; La Motta C
    Cell Chem Biol; 2018 Nov; 25(11):1414-1418.e3. PubMed ID: 30122369
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes.
    Naruse K; Nakamura J; Hamada Y; Nakayama M; Chaya S; Komori T; Kato K; Kasuya Y; Miwa K; Hotta N
    Exp Eye Res; 2000 Sep; 71(3):309-15. PubMed ID: 10973739
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Role of aldose reductase in the progression of diabetic retinopathies].
    Akagi Y; Kubo E
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():194-201. PubMed ID: 15999706
    [No Abstract]   [Full Text] [Related]  

  • 73. Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications.
    Jannapureddy S; Sharma M; Yepuri G; Schmidt AM; Ramasamy R
    Front Endocrinol (Lausanne); 2021; 12():636267. PubMed ID: 33776930
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Aldose reductase and diabetic retinopathy.
    Singh R; Dash D; Ansari FJ; Maurya OP; Singh VP
    Ann Ophthalmol; 1992 Nov; 24(11):420-2. PubMed ID: 1476398
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Aldose reductase inhibitors and the complications of diabetes mellitus.
    Tomlinson DR
    Diabet Med; 1993 Apr; 10(3):214-30. PubMed ID: 8485953
    [No Abstract]   [Full Text] [Related]  

  • 76. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury.
    Ramasamy R; Oates PJ; Schaefer S
    Diabetes; 1997 Feb; 46(2):292-300. PubMed ID: 9000707
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Discoveries in research on diabetic keratopathy.
    Cisarik-Fredenburg P
    Optometry; 2001 Nov; 72(11):691-704. PubMed ID: 12363257
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Natural Compounds as Source of Aldose Reductase (AR) Inhibitors for the Treatment of Diabetic Complications: A Mini Review.
    Grewal AS; Thapa K; Kanojia N; Sharma N; Singh S
    Curr Drug Metab; 2020; 21(14):1091-1116. PubMed ID: 33069193
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Norman MacAlister Gregg Lecture. The pathogenesis of diabetic retinopathy.
    Larkins RG; Dunlop ME; Johnson EI
    Aust N Z J Ophthalmol; 1996 May; 24(2):97-104. PubMed ID: 9199738
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development of novel pyrazolone derivatives as inhibitors of aldose reductase: an eco-friendly one-pot synthesis, experimental screening and in silico analysis.
    Kadam A; Dawane B; Pawar M; Shegokar H; Patil K; Meshram R; Gacche R
    Bioorg Chem; 2014 Apr; 53():67-74. PubMed ID: 24607578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.